Studies suggest that semaglutide reduces heart attack and stroke and may curb addiction and more. Scientists reflect on the future of GLP-1 drugs beyond weight loss.

A new study published in the journal of Movement Disorders showed that Parkinson's disease (PD) was found to be independently ...

Philip Stevens, a 66 year old from Hampshire, has received £70,000 from his GP following a lawsuit after he was given the ...

Parkinson’s disease is a challenging condition that affects millions of people around the world. It is known for causing ...

People with Parkinson’s disease are to benefit from cutting edge AI technology that allows neuroscientists to safely test medication and treatment on a ‘digital twin’ brain, thanks to a £1m funding ...

Tavapadon aims to treat Parkinson’s motor symptoms by mimicking dopamine in a once-a-day oral dose. And the pivotal, ...

Trichloroethylene and perchloroethylene are known to cause multiple types of cancer as well as damage to vital organs.

The new Ochsner site will contribute to uncovering additional genes as well as examine health disparities and care access for ...

The US Environmental Protection Agency on Monday banned the use of two ubiquitous cancer-causing solvents that activists have been targeting for decades.

Boston-based CervoMed (CRVO) said the Phase 2b trial of its neflamapimod did not meet significant statistical thresholds for its primary endpoint of a change in the Clinical Dementia Rating Sum of ...

Parkinson’s disease is a progressive neurological disorder in which ongoing changes in the brain affect and interfere with ...

Commonly prescribed drugs could increase risk of dementia, scientists have warned. Research conducted by the University of ...